Ahn, Linda

Memorial Sloan Kettering Cancer Center

1 paper on CoChatORCID 0000-0001-9347-5854

Most cited papers

Verified
Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers
Drilon, A., Schoenfeld, A. J., Arbour, K. C., Litvak, A., Ni, A., Montecalvo, J., Yu, H. A., Panora, E., Ahn, L., Kennedy, M., et al. (2019) · Molecular Case Studies
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 31

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free